# ADAR1 Capital Management, LLC 13F Q2 2026: $2.2 billion

ADAR1 Capital Management, LLC reported $2.2 billion in 13F securities across 277 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Abivax SA at $240 million, 11.0% of the reported value. Since Q1 2026 it opened 47 new positions and exited 80.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $2,185,183,006
- Positions: 277
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1940272
- Form 13F file number: 028-23931
- CRD number: 299694
- Business address: 3503 Wild Cherry Drive Building 9, Austin, TX 78738
- SEC filing: [0001940272-26-000015](https://www.sec.gov/Archives/edgar/data/1940272/000194027226000015/0001940272-26-000015-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/adar1-capital-management-llc-299694)

## Top 25 holdings by value

The largest of 277 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 1,804,703 | $240.5 million | +410,684 |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 960,863 | $117.8 million | -33,256 |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 3,157,008 | $111.7 million | -128,898 |
| [State STR SPDR S&P 500 ETF T](https://specstream.ai/data/institutional-holders/state-str-spdr-s-p-500-etf-t-78462f103) | TR UNIT | 129,087 | $96.4 million | +53,147 |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 2,330,716 | $89.8 million | -348,294 |
| [Zai Lab LTD](https://specstream.ai/data/institutional-holders/zai-lab-ltd-98887q104) | ADR | 3,369,034 | $64 million | +1,943,667 |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 1,288,053 | $47.8 million | +1,147,381 |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 1,222,080 | $45.7 million | +82,749 |
| [Ea Series Trust](https://specstream.ai/data/institutional-holders/ea-series-trust-02072l565) | ALPHA ARCH 1-3 | 337,125 | $39.5 million | No change |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 457,907 | $39 million | -174,649 |
| [Septerna Inc](https://specstream.ai/data/institutional-holders/septerna-inc-81734d104) | COM | 940,747 | $31.5 million | -149,071 |
| [Anteris Technologies Global](https://specstream.ai/data/institutional-holders/anteris-technologies-global-03675p102) | COM | 3,145,096 | $31 million | -644,036 |
| [Editas Medicine Inc](https://specstream.ai/data/institutional-holders/editas-medicine-inc-28106w103) | COM | 8,889,000 | $28.8 million | New |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 1,029,080 | $26.5 million | -842,375 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 283,982 | $25.2 million | -54,341 |
| [Vir Biotechnology Inc](https://specstream.ai/data/institutional-holders/vir-biotechnology-inc-92764n102) | COM | 2,456,677 | $25 million | -288,037 |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 74,253 | $24.9 million | +72,753 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 228,520 | $24.4 million | +193,128 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 619,542 | $23.1 million | +191,726 |
| [Viking Therapeutics Inc](https://specstream.ai/data/institutional-holders/viking-therapeutics-inc-92686j106) | COM | 574,038 | $22.4 million | +346,321 |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 3,040,466 | $20.7 million | +61,037 |
| [Monopar Therapeutics Inc](https://specstream.ai/data/institutional-holders/monopar-therapeutics-inc-61023l207) | COM NEW | 217,595 | $20.1 million | -46,683 |
| [Ovid Therapeutics Inc](https://specstream.ai/data/institutional-holders/ovid-therapeutics-inc-690469101) | COM | 7,417,479 | $20 million | +2,873,366 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 387,718 | $19.7 million | +58,178 |
| [Enanta Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/enanta-pharmaceuticals-inc-29251m106) | COM | 1,344,510 | $19.6 million | +1,293,153 |

## New positions in Q2 2026

47 positions not in the filing for the quarter ended March 31, 2026. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Editas Medicine Inc](https://specstream.ai/data/institutional-holders/editas-medicine-inc-28106w103) | COM | 8,889,000 | $28.8 million |
| State STR SPDR S&P 500 ETF T | TR UNIT (put) | 25,000 | $18.7 million |
| [Vor Biopharma Inc](https://specstream.ai/data/institutional-holders/vor-biopharma-inc-929033207) | COM NEW | 680,626 | $12.5 million |
| [Faeth Therapeutics Inc](https://specstream.ai/data/institutional-holders/faeth-therapeutics-inc-81728a207) | COM NEW | 361,010 | $9 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 28,604 | $7.6 million |
| [Amanat Acquisition Corp](https://specstream.ai/data/institutional-holders/amanat-acquisition-corp-g0375m101) | CL A ORD | 750,000 | $7.6 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 650,000 | $7 million |
| [Relay Therapeutics Inc](https://specstream.ai/data/institutional-holders/relay-therapeutics-inc-75943r102) | COM | 358,333 | $6.7 million |
| [Disciplined Growth](https://specstream.ai/data/institutional-holders/disciplined-growth-g2775w127) | UNIT 99/99/9999 | 500,000 | $5 million |
| [Boundless Bio Inc](https://specstream.ai/data/institutional-holders/boundless-bio-inc-10170a100) | COM | 1,968,216 | $4.9 million |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 146,447 | $4.8 million |
| [Jatt II Acquisition Corp](https://specstream.ai/data/institutional-holders/jatt-ii-acquisition-corp-g50765109) | ORD SHS | 417,724 | $4.7 million |
| [Rein Therapeutics Inc](https://specstream.ai/data/institutional-holders/rein-therapeutics-inc-00887a204) | COM NEW | 4,500,000 | $4.7 million |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 31,000 | $4.1 million |
| [Engene Therapeutics Inc](https://specstream.ai/data/institutional-holders/engene-therapeutics-inc-29286x101) | COM | 2,104,986 | $3.6 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 437,500 | $3.4 million |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 55,193 | $1.7 million |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 71,910 | $1.4 million |
| [Inmed Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/inmed-pharmaceuticals-inc-457637700) | COM NEW | 800,000 | $1.2 million |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280aac4) | NOTE 1/1 (principal) | 10,000 | $1.2 million |
| [Artiva Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/artiva-biotherapeutics-inc-04317a107) | COM | 118,624 | $1.2 million |
| [Alx Oncology Hldgs Inc](https://specstream.ai/data/institutional-holders/alx-oncology-hldgs-inc-00166b105) | COM | 533,660 | $1.1 million |
| [Cartesian Therapeutics Inc](https://specstream.ai/data/institutional-holders/cartesian-therapeutics-inc-816212302) | COM NEW | 98,877 | $1 million |
| [Cyclerion Therapeutics Inc](https://specstream.ai/data/institutional-holders/cyclerion-therapeutics-inc-23255m204) | COM | 298,757 | $1 million |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422gab3) | NOTE 0.500% 5/1 (principal) | 10,000 | $1 million |

## Positions exited in Q2 2026

80 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Terns Pharmaceuticals Inc | COM | 914,699 | $48.2 million |
| [Beam Therapeutics Inc](https://specstream.ai/data/institutional-holders/beam-therapeutics-inc-07373v105) | COM | 1,446,375 | $34.5 million |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 407,273 | $20 million |
| Terns Pharmaceuticals Inc | COM (call) | 200,000 | $10.5 million |
| [Vertex Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/vertex-pharmaceuticals-inc-92532f100) | COM | 15,075 | $6.7 million |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 304,422 | $6 million |
| Ascendis Pharma A/S | SPONSORED ADR | 25,014 | $5.7 million |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 5,060 | $4.7 million |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 55,000 | $4.6 million |
| [Belite Bio Inc](https://specstream.ai/data/institutional-holders/belite-bio-inc-07782b104) | SPONSORED ADS | 26,880 | $4.3 million |
| Liquidia Corporation | COM NEW (put) | 100,000 | $3.8 million |
| Arcellx Inc | COMMON STOCK | 32,084 | $3.7 million |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 141,814 | $3.3 million |
| Apellis Pharmaceuticals Inc | COM | 72,500 | $2.9 million |
| Masimo Corp | COM | 15,000 | $2.7 million |
| [Teleflex Incorporated](https://specstream.ai/data/institutional-holders/teleflex-incorporated-879369106) | COM | 21,186 | $2.5 million |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 135,560 | $2.4 million |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 46,400 | $1.6 million |
| Uniqure NV | SHS (call) | 100,000 | $1.6 million |
| Soleno Therapeutics Inc | COM | 46,830 | $1.6 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 38,566 | $1.5 million |
| Amicus Therapeutic | COM | 105,000 | $1.5 million |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 5,501 | $1.5 million |
| [Sensient Technologies Corp](https://specstream.ai/data/institutional-holders/sensient-technologies-corp-81725t100) | COM | 15,000 | $1.3 million |
| [Schrodinger Inc](https://specstream.ai/data/institutional-holders/schrodinger-inc-80810d103) | COM | 101,500 | $1.2 million |

## Also on SpecStream

- [ADAR1 Capital Management, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1940272/000194027226000015/0001940272-26-000015-index.htm)
- [ADAR1 Capital Management, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/adar1-capital-management-llc-299694)
- [Largest 13F filers in Texas](https://specstream.ai/data/institutional-holdings/state/texas)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Austin, Texas

- [American restaurants in Austin, Texas](https://specstream.ai/data/businesses/american-restaurants/austin-texas-united-states)
- [Bars in Austin, Texas](https://specstream.ai/data/businesses/bars/austin-texas-united-states)
- [Child care centers in Austin, Texas](https://specstream.ai/data/businesses/child-care-centers/austin-texas-united-states)
- [Damage restoration companies in Austin, Texas](https://specstream.ai/data/businesses/damage-restoration-companies/austin-texas-united-states)
- [Employment agencies in Austin, Texas](https://specstream.ai/data/businesses/employment-agencies/austin-texas-united-states)
- [Graphic design firms in Austin, Texas](https://specstream.ai/data/businesses/graphic-design-firms/austin-texas-united-states)
